These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 30740635

  • 1. Metabolomic and lipidomic characterization of Oxalobacter formigenes strains HC1 and OxWR by UHPLC-HRMS.
    Chamberlain CA, Hatch M, Garrett TJ.
    Anal Bioanal Chem; 2019 Jul; 411(19):4807-4818. PubMed ID: 30740635
    [Abstract] [Full Text] [Related]

  • 2. Oxalobacter formigenes produces metabolites and lipids undetectable in oxalotrophic Bifidobacterium animalis.
    Chamberlain CA, Hatch M, Garrett TJ.
    Metabolomics; 2020 Nov 21; 16(12):122. PubMed ID: 33219444
    [Abstract] [Full Text] [Related]

  • 3. Metabolomic Alteration in the Mouse Distal Colonic Mucosa after Oral Gavage with Oxalobacter formigenes.
    Chamberlain CA, Hatch M, Garrett TJ.
    Metabolites; 2020 Oct 13; 10(10):. PubMed ID: 33065971
    [Abstract] [Full Text] [Related]

  • 4. Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells.
    Arvans D, Chang C, Alshaikh A, Tesar C, Babnigg G, Wolfgeher D, Kron S, Antonopoulos D, Bashir M, Cham C, Musch M, Chang E, Joachimiak A, Hassan H.
    Am J Physiol Cell Physiol; 2023 Jul 01; 325(1):C344-C361. PubMed ID: 37125773
    [Abstract] [Full Text] [Related]

  • 5. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.
    Canales BK, Hatch M.
    Surg Obes Relat Dis; 2017 Jul 01; 13(7):1152-1157. PubMed ID: 28552742
    [Abstract] [Full Text] [Related]

  • 6. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
    Daniel SL, Moradi L, Paiste H, Wood KD, Assimos DG, Holmes RP, Nazzal L, Hatch M, Knight J.
    Appl Environ Microbiol; 2021 Aug 26; 87(18):e0054421. PubMed ID: 34190610
    [Abstract] [Full Text] [Related]

  • 7. Oxalobacter formigenes: A new hope as a live biotherapeutic agent in the management of calcium oxalate renal stones.
    Hiremath S, Viswanathan P.
    Anaerobe; 2022 Jun 26; 75():102572. PubMed ID: 35443224
    [Abstract] [Full Text] [Related]

  • 8. Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis.
    Vaidyanathan S, von Unruh GE, Watson ID, Laube N, Willets S, Soni BL.
    ScientificWorldJournal; 2006 Apr 06; 6():2403-10. PubMed ID: 17619709
    [Abstract] [Full Text] [Related]

  • 9. Oxalobacter formigenes and its role in oxalate metabolism in the human gut.
    Stewart CS, Duncan SH, Cave DR.
    FEMS Microbiol Lett; 2004 Jan 15; 230(1):1-7. PubMed ID: 14734158
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.
    Pape L, Ahlenstiel-Grunow T, Birtel J, Krohne TU, Hoppe B.
    Pediatr Nephrol; 2020 Jun 15; 35(6):1121-1124. PubMed ID: 32107618
    [Abstract] [Full Text] [Related]

  • 14. Oxalobacter formigenes and its potential role in human health.
    Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS.
    Appl Environ Microbiol; 2002 Aug 15; 68(8):3841-7. PubMed ID: 12147479
    [Abstract] [Full Text] [Related]

  • 15. [Oxalobacter formigenes--characteristics and role in development of calcium oxalate urolithiasis].
    Torzewska A.
    Postepy Hig Med Dosw (Online); 2013 Nov 27; 67():1144-53. PubMed ID: 24379255
    [Abstract] [Full Text] [Related]

  • 16. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
    Ariceta G, Collard L, Abroug S, Moochhala SH, Gould E, Boussetta A, Ben Hmida M, De S, Hunley TE, Jarraya F, Fraga G, Banos A, Lindner E, Dehmel B, Schalk G.
    Pediatr Nephrol; 2023 Feb 27; 38(2):403-415. PubMed ID: 35552824
    [Abstract] [Full Text] [Related]

  • 17. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition.
    Verhulst A, Dehmel B, Lindner E, Akerman ME, D'Haese PC.
    Urolithiasis; 2022 Apr 27; 50(2):119-130. PubMed ID: 35122487
    [Abstract] [Full Text] [Related]

  • 18. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA, Sidhu H, Kaul P, Low RK.
    J Endourol; 2003 Apr 27; 17(3):173-6. PubMed ID: 12803990
    [Abstract] [Full Text] [Related]

  • 19. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes.
    Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB.
    J Urol; 2001 Oct 27; 166(4):1487-91. PubMed ID: 11547118
    [Abstract] [Full Text] [Related]

  • 20. New perspectives on an old grouping: The genomic and phenotypic variability of Oxalobacter formigenes and the implications for calcium oxalate stone prevention.
    Chmiel JA, Carr C, Stuivenberg GA, Venema R, Chanyi RM, Al KF, Giguere D, Say H, Akouris PP, Domínguez Romero SA, Kwong A, Tai V, Koval SF, Razvi H, Bjazevic J, Burton JP.
    Front Microbiol; 2022 Oct 27; 13():1011102. PubMed ID: 36620050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.